A Research Study of VCT220 in Adult Chinese Participants With Obesity

Summary

The main purpose of this study is to assess how VCT220 tablets affect the bodyweight in obese or overweight adult participants. Participant will be randomly assigned to the high-dose group, low-dose group, or placebo group. Each participant will take the study drug orally once daily for 12 months.

Timeline

Start

2024-12-24

Primary completion

2025-11-25

Completion

2026-03-31

Drugs

Indications